Press release: Mosaic
Exotic protein pioneer, Mosaic Pet Food, a brand of Boston Treat House, has received an investment from one of the largest ostrich farms in the world, officially making Mosaic the number one global pet industry leading brand for the exotic protein sector.
The partnership will give Mosaic the opportunity to expand into other consumable categories including a revolutionary hypoallergenic dog and cat food, exotic body parts, innovative supplements and more.
As it continues supplying the high demand throughout the U.S.A., Mosaic will also expand distribution to other continents, as it now has the ability to sustainably produce multiple container-size volumes of exotic consumables on a monthly basis, using its own state-of-the-art, certified manufacturing facilities, while making an eco-friendly impact for our planet. Raising ostriches uses 98 percent less land and 99 percent less water than raising cattle.
Jared Shlager, CEO of Mosaic Pet Food, explained how the brand’s main focus is to utilize sustainably-sourced exotic proteins to solve major pet health problems, such as food allergies, while using new food science methods to disrupt the way pet food and consumables are manufactured. Shlager plans to start new trends throughout the pet industry to motivate other manufacturers to help him build a better future for animal health and wellness.
Year after year, the number of cases for food allergy symptoms due to the consumption of common proteins (chicken, beef, pork, lamb) are increasing. Many dogs with skin disorders and digestive issues have underlying food sensitivities as well.
Shlager states: “These major health problems are increasing the pet owner’s demands for exotic, nonallergenic consumables. Mosaic has the supply capabilities to support the high demand throughout the global pet industry. Business aside, it’s my moral responsibility to heal all animals from any suffering.”
Mosaic also provides other unique proteins, such as wild-caught octopus, and plans to offer the largest variety of exotic proteins in the industry by 2023.